KR20210083518A - Rhinitis therapy apparatus and method for operating thereof - Google Patents

Abstract

The present invention relates to a device for treating rhinitis. The device comprises: a body unit provided to cover the user's nose; a cushion unit provided to be in contact with the front surface of the body unit, having a front surface in contact with the user's skin, and providing a cushioning feeling to the skin; a magnetic field generation unit provided to correspond to the front surface of the cushion unit and irradiating a magnetic field toward the nose; and a control unit for controlling the operation of the magnetic field generation unit. The rhinitis treatment for the nose region can be performed by the magnetic field irradiated from the magnetic field generation unit.

Description

Rhinitis treatment device and its driving method {RHINITIS THERAPY APPARATUS AND METHOD FOR OPERATING THEREOF}

The present application relates to a device for treating rhinitis and a method for driving the same.

Rhinitis refers to an inflammatory disease of the nasal mucosa accompanied by one or more symptoms of runny nose, sneezing, itching and nasal congestion. Acute rhinitis is an infectious rhinitis that often refers to a cold, and chronic rhinitis caused by bacteria may appear when rhinitis occurs repeatedly due to incomplete treatment for acute rhinitis.

Most chronic rhinitis patients complain of nasal congestion, but if left untreated, breathing through the nose becomes impaired, leading to oral breathing through the mouth, which makes it easy to get a sore throat and frequent sore throat. In addition, headaches and stress can cause distraction and difficulty in concentration, which can cause significant disruption to work and studies.

Conventionally, as a treatment technique for rhinitis, the following techniques exist. For example, in the case of allergic rhinitis in Western medicine, steroids are used to treat rhinitis, which is effective only when the drug is administered, and has a problem of recurrence when exposed to the allergen again.

In addition, there is a treatment called 'immunotherapy' that relieves symptoms by regulating the patient's immune response by administering the causative allergen to the patient from a small amount to gradually increasing the concentration. However, there is a problem that it is difficult to cure rhinitis 100% even after investing such a huge amount of time and money.

The technology that is the background of the present application is disclosed in Korean Patent Application Laid-Open No. 10-2015-0056102.

The present application aims to solve the problems of the prior art described above, and to provide a portable rhinitis treatment device and a driving method thereof that increase the effect of rhinitis treatment and allow rhinitis treatment to be performed anytime and anywhere regardless of location do it with

An object of the present application is to provide a rhinitis treatment device capable of treating rhinitis with a low possibility of recurrence and a simple treatment with easy use, and a driving method thereof, in order to solve the problems of the prior art described above.

However, the technical problems to be achieved by the embodiments of the present application are not limited to the technical problems as described above, and other technical problems may exist.

As a technical means for achieving the above technical problem, the rhinitis treatment device according to the first aspect of the present application, the body portion provided so as to cover the user's nose portion; a cushion unit provided to be in contact with the front surface of the body part, having a front surface in contact with the user's skin, and providing a cushioning feeling to the skin; a magnetic field generator provided to correspond to the front surface of the cushion unit and irradiating a magnetic field toward the nose; And it includes a control unit for controlling the operation of the magnetic field generator, rhinitis treatment for the nose region by the magnetic field irradiated from the magnetic field generator can be made.

As a technical means for achieving the above technical problem, the driving method of the rhinitis treatment device according to the second aspect of the present application, the control unit, a cushion unit provided to contact the front surface of the body portion provided to cover the user's nose region controlling the operation of the magnetic field generator provided to correspond to the front surface of the; The magnetic field generator includes the step of irradiating a magnetic field toward the nose area by the control, rhinitis treatment is made on the nose area by the magnetic field irradiated from the magnetic field generator, and the cushion unit is the user's It may provide a cushioning feeling to the skin and may have a front surface in contact with the user's skin.

The above-described problem solving means are merely exemplary, and should not be construed as limiting the present application. In addition to the exemplary embodiments described above, additional embodiments may exist in the drawings and detailed description.

According to the above-described means for solving the problems of the present application, the magnetic field is irradiated to the user's nose area non-invasively, rather than by an invasive method such as drug injection, so that the treatment is simple with ease of use and the possibility of recurrence is low. It is possible to provide a device for treating rhinitis that can be treated.

According to the above-described problem solving means of the present application, it is possible to provide a portable rhinitis treatment device that enhances the effect of rhinitis treatment and allows rhinitis treatment to be performed anytime and anywhere regardless of location.

According to the problem solving means of the present application described above, it is possible to maximize the rhinitis treatment effect by intensive or effective magnetic field stimulation for the user's skin (especially the nose region).

According to the above-described problem solving means of the present application, it is possible to provide a rhinitis treatment device that allows the user to use it for a long time without putting much effort.

In addition, in the present application, as the magnetic field irradiated from the rhinitis treatment device can be irradiated not only toward the user's nose, but also toward the area under the eyes, the user's skin (skin such as the nose area, the area under the eyes, and the cheek area) It can regenerate collagen and increase skin elasticity, and improve tone (ie, dark circles) for the area under the eyes through excessive vascular changes and improvement of blood flow. That is, the present application can provide an effect of improving not only rhinitis treatment but also dark circles under the eyes through the provision of a rhinitis treatment device.

This hospital can improve not only rhinitis treatment but also dark circles through the provision of a rhinitis treatment device, and dark circles that cause not only health problems but also aesthetic problems by showing the impression of tired or depressed look, presbyopia, etc. It can be effectively improved (treated).

However, the effects obtainable herein are not limited to the above-described effects, and other effects may exist.

1 is a view showing a state when a user wears a rhinitis treatment device according to an embodiment of the present application.
2 is a block diagram showing a schematic configuration of a rhinitis treatment apparatus according to an embodiment of the present application.
3 is a perspective view of a rhinitis treatment apparatus according to an embodiment of the present application.
4 is a perspective view of the rhinitis treatment apparatus according to an embodiment of the present application viewed from an angle different from FIG. 3 .
5 is a front view of the rhinitis treatment apparatus according to an embodiment of the present application.
6 and 7 are plan views of the rhinitis treatment apparatus according to an embodiment of the present application.
8 is a diagram schematically showing the configuration of a magnetic field generator in the rhinitis treatment device according to an embodiment of the present application.
9 is a view showing an example of the type of magnetic field stimulation mode considered in the rhinitis treatment device according to an embodiment of the present application.
10 is a view for explaining the extension of the rhinitis treatment apparatus according to an embodiment of the present application.
11 is an operation flowchart for a method of driving a rhinitis treatment apparatus according to an embodiment of the present application.
12 and 13 are views for explaining the effect of the magnetic field generated through the magnetic field generator of the rhinitis treatment apparatus according to an embodiment of the present application.
14 is a view showing an example of a magnetic field generator in the rhinitis treatment device according to an embodiment of the present application.
15 is a diagram for explaining a design example of a small electronic circuit as hardware included in the rhinitis treatment apparatus according to an embodiment of the present application.
16 is a view for explaining the frequency of the magnetic field generated from the magnetic field generator of the rhinitis treatment device according to an embodiment of the present application.
17 is a view for explaining an example of a small drive hardware included in the rhinitis treatment apparatus according to another embodiment of the present application.
18 is a view schematically showing the shape of the rhinitis treatment apparatus according to an embodiment of the present application.

Hereinafter, embodiments of the present application will be described in detail with reference to the accompanying drawings so that those of ordinary skill in the art to which the present application pertains can easily implement them. However, the present application may be embodied in several different forms and is not limited to the embodiments described herein. And in order to clearly explain the present application in the drawings, parts irrelevant to the description are omitted, and similar reference numerals are attached to similar parts throughout the specification.

Throughout this specification, when a part is "connected" with another part, it is not only "directly connected" but also "electrically connected" or "indirectly connected" with another element interposed therebetween. "Including cases where

Throughout this specification, when it is said that a member is positioned "on", "on", "on", "under", "under", or "under" another member, this means that a member is positioned on the other member. It includes not only the case where they are in contact, but also the case where another member exists between two members.

Throughout this specification, when a part "includes" a component, it means that other components may be further included, rather than excluding other components, unless otherwise stated.

1 is a view showing a state when the user 1 wears (in contact with the user's skin) the rhinitis treatment apparatus 100 according to an embodiment of the present application. 2 is a block diagram showing a schematic configuration of the rhinitis treatment apparatus 100 according to an embodiment of the present application. 3 is a perspective view of the rhinitis treatment apparatus 100 according to an embodiment of the present application. 4 is a perspective view of the rhinitis treatment apparatus 100 according to an embodiment of the present application viewed from an angle different from that of FIG. 3 . 5 is a front view of the rhinitis treatment apparatus 100 according to an embodiment of the present application. 6 and 7 are plan views of the rhinitis treatment apparatus 100 according to an embodiment of the present application.

Hereinafter, the device 100 for treating rhinitis according to an embodiment of the present application will be referred to as the device 100 for convenience of description.

In addition, below, in describing the rhinitis treatment apparatus 100 according to an embodiment of the present application, the 2 o'clock-8 o'clock direction is the front-back direction, and the 4 o'clock-10 o'clock direction is left and right based on the drawing of FIG. 3 . The direction, 12 o'clock - 6 o'clock, will be referred to as the up-down direction. However, this direction setting is only an example for helping understanding of the present application, and is not limited thereto.

1 to 7, the present device 100 relates to a rhinitis treatment device capable of treating (improving) rhinitis. However, it is not limited thereto, and the device 100 not only treats rhinitis, but also improves dark circles by irradiating a magnetic field to the area under the user's eyes, and the user 1's face or eyes (especially, It may be a device that can care (improve) the skin for the area under the eyes). This device 100 may be expressed differently as a rhinitis treatment device, an eye-lightening device, a skin beauty device, and the like.

The device 100 includes a body part 110 , a cushion unit 120 , a magnetic field generator 130 , a control unit 140 , a reflection intensity measurement unit 150 , a position adjustment unit 160 , and a sleep state determination unit (170).

The body part 110 may be provided so as to cover the user 1's nose region. In addition, the body part 110 may be provided to cover not only the nose part of the user 1 but also the part under the eyes (or the cheek region, in particular, the front cheek region). Accordingly, the body portion 110 may be provided to cover the area under both eyes of the user 1 and to cross the bridge of the nose of the user 1 .

The body portion 110 may have a horizontal length longer than a vertical length. Here, the horizontal length may mean a length in the left and right direction, and the vertical length may mean a length in the vertical direction.

In other words, when the device 100 is worn (mounted, mounted) on the face of the user 1 , the body 110 is located on the user's 1 nose (particularly, the bridge of the nose) as shown in FIG. 1 . area) and may be disposed at a position to cover the area under both eyes of the user 1 .

Referring to the plan view of FIG. 6 , the body part 110 may be formed in a curved shape protruding toward the rear side, for example. In other words, the body portion 110 may be formed of a curved surface.

The cushion unit 120 may be provided to be in contact with the front surface of the body part 110 , and may have a front surface ts that is in contact with the skin (face part) of the user 1 . The cushion unit 120 may provide a cushioning feeling to the skin of the user 1 .

The front surface ts of the cushion unit 120 is designed to prevent contamination by contact with the user 1's face (especially, under the eyes or nose), for example, a metal (metal) material (material), etc. can be made with However, the present invention is not limited thereto, and various materials (materials) for preventing contamination may be applied to the front surface ts. In addition, the cushion unit 120 may be made of a metal material or the like not only on the front surface ts but also on the entire surface exposed to the outside.

In addition, the cushion unit 120 may be made of a material that acts as a buffer against an impact or the like.

The cushion unit 120 may be made of, for example, a soft material such as memory foam or latex, a light material such as coconut palm, cotton, air, etc. have. However, the present invention is not limited thereto, and the cushion unit 120 may be made of various materials capable of providing a cushioning feeling.

The central portion 126 of the cushion unit 120 may be recessed in the rear direction compared to both side portions 124 , 121 and 122 of the cushion unit 120 . In addition, the central front surface (cs), which is the front surface of the central part 126, is the nose region of the user 1 when the rhinitis treatment device 100 is in contact with the skin of the user 1 (ie, when worn on the user's face). (In particular, it may be a surface that is provided (seated) at a position corresponding to (in particular, the bridge of the nose). This central front (cs) may form a curved surface. The central front (cs) may be curved to surround the user's bridge of the nose. have.

Both side portions 124 , 121 , and 122 may include a first side portion 121 provided on one side of the central portion 126 and a second side portion 122 provided on the other side of the central portion 126 . . Here, for example, one side may mean the left side of the central part 126 , and the other side may mean the right side of the central part 126 . 5 and 6 , p1 may mean a position corresponding to one end of the central part 126 , and p2 may mean a position corresponding to the other end of the central part 126 .

The first front surface s1, which is the front surface of the first side part 121, and the second front surface s2, which is the front surface of the second side part 122, are provided at positions corresponding to the eye area of the user 1 (seated). ) may be the side.

In other words, when the device 100 is in contact with the user's skin (that is, when the device is worn on the user's face), for example, among the first front surface s1 of the first side part 121 . At least a portion may be provided to contact the user's left cheek area (or the user's left eye area). In addition, at least a portion of the second front surface s2 that is the front surface of the second side part 122 may be provided to contact the user's right cheek region (or the user's right lower eye region). At least a portion of the central front surface cs that is the front surface of the central portion 126 may be provided to contact the user's nose (particularly, the bridge of the nose).

The first front surface s1 and the second front surface s2 may be curved to surround (enclose) the user 1's under-eye region (or cheekbones).

The first front surface s1 that is the front surface of the first side part 121 and the second front surface s2 that is the front surface of the second side part 122 may each have a curved shape slightly depressed in the rear direction. That is, each of the first front surface s1 and the second front surface s2 may be formed in a curved shape recessed in a rearward direction when viewed from a plane as shown in FIG. 6 . In other words, the first front surface s1 and the second front surface s2 may each form a curved surface. Also, the first front surface s1 and the second front surface s2 may be provided in an oblique direction inclined toward the center of the central front surface cs, for example.

According to this, the front surface ts of the cushion unit 120 is the first front surface s1 that is the front surface of the first side part 121 , the second front surface s2 that is the front surface of the second side part 122 , and the central part It may include a central front surface (cs), which is the front surface of (126).

In this device 100, the first front surface (s1) and the second front surface (s2) are formed to be inclined toward the center of the central front surface (cs), and the central part 126 is recessed while forming a curved surface toward the rear direction. By being formed in a shape, it is possible to provide the device 100 to be more stable and accurately worn (mounted, seated) in the nose or under the eyes of the user 1 in consideration of the user's facial shape (curvature).

In at least a partial area (for example, the first area) of the front surface ts of the cushion unit 120, when the rhinitis treatment device (the device, 100) is in contact with the skin of the user 1 (ie, the user's face) An anti-slip part (not shown) having a predetermined fixing force so as not to slip on the skin when the device is worn on the site may be provided.

Here, the non-slip portion (not shown) provided in one region (the first region) of the front surface ts of the cushion unit 120 is exemplarily set at a predetermined interval in the vertical direction with respect to the front surface corresponding to the first region. It may include a plurality of protrusions (not shown) that are disposed at each doedoe and are provided in a shape protruding from the front side corresponding to the first region toward the omnidirectional side.

An anti-slip part (not shown) including a plurality of protrusions can provide a predetermined fixing force to the skin when the device 100 is in contact with the user's skin, and through this, the device 100 can It can be made more stable to be worn on the skin.

As another example, the non-slip part (not shown) may be made of an anti-slip material having a predetermined fixing force or a predetermined adhesive force to prevent the device 100 from sliding on the skin when it comes into contact with the user's skin. The non-slip material may be, for example, rubber, gel, or the like, but is not limited thereto.

The magnetic field generator 130 may be provided to correspond to the front surface ts of the cushion unit 120 and may irradiate a magnetic field toward the user's nose (or under the eyes).

The magnetic field generator 130 may include a first magnetic field generator 131 and a second magnetic field generator 132 . The first magnetic field generator 131 may be provided to correspond to the first front surface s1 of the first side part 121 among both side parts 124 , 121 and 122 of the cushion unit 120 . The second magnetic field generator 132 may be provided to correspond to the second front surface s2 of the second side part 122 among both side parts 124 , 121 and 122 of the cushion unit 120 .

Hereinafter, in describing the apparatus 100 , the descriptions of the magnetic field generator 130 are for each of the first magnetic field generator 131 and the second magnetic field generator 132 even if omitted below. The same may be applied to the description. The configuration of the magnetic field generator 130 , 131 , 132 may be more easily understood with reference to FIG. 8 .

8 is a view schematically showing the configuration of the magnetic field generator 130 in the rhinitis treatment apparatus 100 according to an embodiment of the present application. At this time, the description of the magnetic field generator 130 described with reference to FIG. 8 is, as described above, the first magnetic field generator 131 and the second magnetic field generator 132, respectively, even if omitted below. The same may be applied to the description. In FIG. 8 , (a) shows an overall coupling diagram of the magnetic field generator 130 as an example, and (b) shows an exploded view of the magnetic field generator 130 .

Referring to FIG. 8 , the magnetic field generator 130 may include two coil guides 133 and 134 , a magnetic material 135 and a coil 136 .

The two coil guides 133 and 134 may be positioned to face each other, and for example, may be made of a plastic material. The magnetic body 135 may be positioned between the two coil guides 133 and 134 to be orthogonal to each of the two coil guides 133 and 134 . In particular, the magnetic body 135 may be inserted into the center hole of each of the two coil guides 133 and 134 . The magnetic material 135 may be a ferromagnetic material having a strong magnetization force, and may be, for example, ferrite or the like. In addition, the magnetic body 135 may be made of, for example, SM45C material.

For example, one surface of the magnetic body 135 may be provided to be exposed toward the front surface ts of the cushion unit 120 , but is not limited thereto, and may be provided in a form embedded in the cushion unit 120 . . The magnetic material 135 may be expressed differently as an electromagnet or the like.

The diameter of the magnetic body 135 may be set to any one of, for example, 2 mm to 5 mm, but is not limited thereto. Also, the diameter of the coil guides 133 and 134 may be set to any one of 10 mm to 25 mm according to the size of the diameter of the magnetic body 135 .

For example, the diameters of the coil guides 133 and 134 may be set in proportion to the size of the diameter of the magnetic body 135 . In addition, in an example of the present application, the distance between the two coil guides 133 and 134 or the length of the magnetic body 135 is to be kept constant regardless of the size of the diameter of the coil guides 133 and 134 or the magnetic body 135 . can The coil 136 may be provided in a form wound around the magnetic body 135 . Also, the coil 136 may be, for example, a solenoid coil.

Examples of specific numerical values in the preceding description are only examples for helping understanding of the present application, and are not limited thereto. In addition, the term "diameter" herein may be broadly interpreted to mean the width (width) of various shapes, rather than being narrowly interpreted to mean the diameter of a circle shape.

The magnetic field generator 130 may be an electromagnet including a core and a coil, for example, a solenoid coil.

In one example of the present application, the magnetic field generator 130 is exemplified as being provided in a built-in form in the cushion unit 120 to correspond to the front surface (ts) of the cushion unit 120 , but is not limited thereto. As another example, the magnetic field generator 130 may have one surface exposed to the front surface ts of the cushion unit 120 . In this case, in particular, one surface of the magnetic body 135 included in the magnetic field generator 130 . It may be provided to be exposed to the front surface ts of the cushion unit 120 .

The magnetic field generator 130 may scan the magnetic field toward the area under the eyes of the user 1 . The first magnetic field generator 131 may irradiate a magnetic field toward the lower left eye of the user 1 , and the second magnetic field generator 132 irradiates the magnetic field toward the lower right eye of the user 1 . can do.

The magnetic field generated from the magnetic field generator 130 may be, for example, a pulsed electromagnetic field (PEMF). In addition, the magnetic field generated from the magnetic field generator 130 may be a static magnetic field or a weak magnetic field having a magnitude of about 1 to 300 Gauss. However, the present invention is not limited thereto, and as another example, the magnetic flux density range of the magnetic field generated through the magnetic field generator 130 may be, for example, 0mT to 100mT (1000 gauss).

The magnetic field generator 130 may be expressed differently as a magnetic field stimulator, a magnetic field irradiation probe, or the like.

The stimulus source through the magnetic field generator 130 may be an electromagnetic field. The magnetic field generator 130 may generate a static electromagnetic field or a time-varying magnetic field (0 kHz to 1 kHz) in a low frequency region. Here, the static magnetic field means a magnetic field generated by applying a constant current (DC) to the magnetic field generator 130, and the time-varying magnetic field means a magnetic field generated by applying a current of a pulse or a sine wave. can

In addition, the magnetic field generator 130 may generate various types of magnetic field stimulation. The type of magnetic field generated from the magnetic field generator 130 is, for example, at least one of a sinewave and a square wave (ie, a monophasic type or a biphasic type), and a pulse wave. may include In other words, a pattern (in other words, a pulse form) among the types of magnetic field generated from the magnetic field generator 130 may include monophasic, biphasic, etc., and these patterns may be selectively controlled by the control of the controller 140 . have.

The operation of the magnetic field generator 130 may be controlled by the control of the controller 140 to be described later. The magnetic field generator 130 may control at least one of the strength (magnetic flux density), frequency, time, and pattern (pulse form) of the magnetic field as a type of the magnetic field under the control of the controller 140 . In addition, the magnetic field generator 130 may control the magnetic field stimulation mode as a type of the magnetic field under the control of the controller 140 .

Information related to the setting of the magnetic field stimulation mode of the magnetic field generator 130 is exemplarily received through a button (physical button) provided in an area of the body 110 or wired/wireless communication with the device 100 The input may be received through a user terminal (not shown) connected through .

In the device 100, preferably, the frequency of the magnetic field from the magnetic field generator 130 is 1.5 kHz, the pattern (pulse form) of the magnetic field is biphasic, and the magnetic field having the strength (magnetic flux density) of 1.5 mT can be irradiated. However, the present invention is not limited thereto.

The controller 140 may control the operation of each unit included in the apparatus 100 .

Also, the controller 140 may control the operation of the magnetic field generator 130 , 131 , 132 . The controller 140 may control at least one of strength, frequency, time, and pattern of the magnetic field as a type of magnetic field generated by the magnetic field generator 130 . Also, the controller 140 may control the magnetic field stimulation mode as the type of the magnetic field generated from the magnetic field generator 130 . The description of the magnetic field stimulation mode of the magnetic field generators 130, 131 and 132 may be more easily understood with reference to FIG. 9 .

9 is a view showing an example of the type of magnetic field stimulation mode considered in the rhinitis treatment apparatus 100 according to an embodiment of the present application. That is, FIG. 9 is a diagram for explaining a magnetic field stimulation mode among types of magnetic fields generated from the magnetic field generator 130 as an example.

Referring to FIG. 9 , the controller 140 may control a magnetic field stimulation mode as a type of a magnetic field generated from the magnetic field generator 130 .

Magnetic field stimulation modes include N pulse stimulation mode, S pulse stimulation mode, alternating N pulse and S pulse stimulation (N/S stimulation) mode, and N pulse continuous stimulation (N continuous stimulation) mode. and S-pulse continuous stimulation (S continuous stimulation) mode.

The control unit 140 controls the magnetic field generator 130 to operate in any one of an N pulse stimulation mode, an S pulse stimulation mode, an alternating stimulation mode of N pulses and S pulses, an N pulse continuous stimulation mode, and an S pulse continuous stimulation mode. can Accordingly, the magnetic field generator 130 generates a magnetic field corresponding to the N pulse stimulation mode, a magnetic field corresponding to the S pulse stimulation mode, a magnetic field corresponding to an alternating stimulation mode of N pulses and S pulses, and a magnetic field corresponding to the N pulse continuous stimulation mode. Any one of the magnetic field and the magnetic field corresponding to the S-pulse continuous stimulation mode may be irradiated toward the area under the eyes of the user 1 .

In other words, the magnetic field generator 130 may generate N pulse magnetic field stimulation through magnetic field irradiation corresponding to the N pulse stimulation mode, and may generate S pulse magnetic field stimulation through magnetic field irradiation corresponding to the S pulse stimulation mode. In addition, the magnetic field generator 130 may generate an N/S alternating magnetic field stimulation by irradiating a magnetic field corresponding to the alternating stimulation mode of the N pulse and the S pulse. In addition, the magnetic field generator 130 generates N-pulse continuous magnetic field stimulation through magnetic field irradiation corresponding to the N-pulse continuous stimulation mode, and generates S-pulse continuous magnetic field stimulation through magnetic field irradiation corresponding to the S-pulse continuous stimulation mode. can

The controller 140 may control the N/S alternating magnetic field stimulation to be generated from the magnetic field generator 130 by changing the current direction of the magnetic field generator 130 . For example, the magnetic field generator 130 may generate an N-pulse stimulus when the current direction is a first direction, and generate an S-pulse stimulus when the current direction is a second direction opposite to the first direction.

The controller 140 may selectively control the strength, frequency, time, pattern (in other words, pulse form), magnetic field stimulation mode, and the like of the magnetic field generated from the magnetic field generator 130 .

By the magnetic field (eg, PEMF) irradiated from the magnetic field generator 130 toward the nose of the user 1, rhinitis treatment for the nose can be performed. In addition, by the magnetic field (for example, PEMF) irradiated from the magnetic field generator 130 toward the under-eye region of the user 1, blood circulation in microvessels corresponding to the user's 1 under-eye region is promoted. can be In addition, by the magnetic field irradiated from the magnetic field generator 130 , dark circles under the eyes of the user 1 may be improved by improving blood flow corresponding to the area under the eyes of the user 1 .

That is, the device 100 can treat the rhinitis of the user 1 by irradiating a magnetic field (eg, PEMF) from the magnetic field generator 130 toward the nose or under the eyes of the user 1 . Rather, it is possible to improve vascular dark circles by improving blood flow of blood vessels corresponding to the area under the eyes.

The magnetic field generator 130 may provide various stimuli (magnetic field stimulation) to the nose and/or under the eyes of the user 1 through magnetic field irradiation.

As a specific example, the magnetic field generator 130 may provide a stimulus related to promoting blood ionization, for example, as a magnetic field stimulus.

The magnetic field generator 130 may apply a magnetic field to the blood corresponding to the nose and/or under the eyes by irradiating the magnetic field to the nose and/or under the eyes of the user 1 . According to this, oxygen (O2) is added to iron (Fe) in the Heme group (four) in the hemoglobin of red blood cells in the blood corresponding to the nose and/or under the eyes by the magnetic field generated from the magnetic field generator 130 . may bind, thereby promoting blood ionization. In other words, the control unit 140 controls the magnetic field generator 130 to generate a magnetic field that promotes blood ionization by binding oxygen to iron ions contained in hemoglobin of red blood cells in the blood. operation can be controlled.

Also, under the control of the controller 140 , the magnetic field generator 130 may generate a pulsed electromagnetic field (PEMF). In this case, an alternating magnetic force (Lorentz force) may be applied to iron ions in hemoglobin of red blood cells in the blood corresponding to the user 1's nose and/or under the eyes, so that the red blood cells in a state of continuity are freely separated As a result, the burning phenomenon can be improved, and blood ionization can be promoted.

The apparatus 100 performs magnetic field stimulation related to promoting blood ionization on blood corresponding to the nose and/or under the eyes of the user 1 through the magnetic field generator 130 to expand blood vessels, improve blood flow, and It may provide effects such as improvement of blood viscosity, blood purification, and the like.

The magnetic field (eg, PEMF) irradiated from the magnetic field generator 130 may expand or contract blood vessels corresponding to the nose and/or under the eyes of the user 1 according to the frequency. According to this, the control unit 140 selectively selects the type (eg, frequency, etc.) of the magnetic field irradiated from the magnetic field generator 130 according to the symptoms/causes of the user 1's nose and/or under the eyes. otherwise controllable.

In addition, the magnetic field generator 130 may provide, for example, a stimulus related to the generation of nitric oxide (NO) as a magnetic field stimulus (ie, a stimulus related to the promotion of at least one of an anticancer action and an antimicrobial action).

Specifically, the magnetic field generator 130 may generate a magnetic field (eg, PEMFs wave) with respect to blood corresponding to the user's nose and/or under the eyes (step 1). In this case, calcium influx via Ca2+ voltage gates may be made by the magnetic field generated from the magnetic field generator 130 (step 2). Accordingly, Calmodulin-Calcium complex is formed (step 3), and Nitric oxide senthase activation by the Calmodulin-Calcium complex is activated (eNOS). Calcium complex) (step 4), nitric oxide may be formed (step 5).

In the process of step 1 to step 5 being performed, Ca2+CaM (in other words, Ca2+/CaM) may be generated by binding of Ca2+ and CaM. A muscle tissue contraction/relaxation effect can be provided by the production of Ca2+CaM. In addition, nitric oxide (NO) may be produced by the bonding of Ca2+CaM and S. By the production of such nitric oxide (NO), an effect of increasing blood and lymph fluid as an anti-inflammateNOory and reducing pain and swelling can be provided. The generated NO can be applied as a growth factor (Growth Factors) to increase cGMP. By this generated NO, effects such as FGF-2 (VEGF) angiogenesis (angiogenesis, Angiogenesis), TNF-α collagen / granulation (Collagen / Granulation), TGF-β remodeling (Remodeling) can be provided .

That is, nitric oxide in the blood corresponding to the nose and/or under the eyes may be generated (formed or increased) by the magnetic field generated from the magnetic field generator 130 , and accordingly, anti-inflammatory action, anticancer action and antimicrobial action At least one of the actions may be promoted. In other words, the control unit 140 causes the magnetic field generator 130 to generate nitric oxide (NO) in the blood to promote at least one of an anti-inflammatory action, an anticancer action, and an antimicrobial action. The operation of the magnetic field generator 130 may be controlled to generate .

The device 100 stimulates the magnetic field related to the promotion of at least one of an anti-inflammatory action, an anticancer action, and an antimicrobial action on blood corresponding to the user's nose and/or under the eyes through the magnetic field generator 130 . By performing the edema and inflammation treatment effect can be provided.

12 and 13 are diagrams for explaining the effect of the magnetic field generated through the magnetic field generator 130 of the rhinitis treatment apparatus 100 according to an embodiment of the present application.

12 and 13 , the device 100 generates a pulsed electromagnetic field (PEMF) as a magnetic field from the magnetic field generator 130 , so that the user 1's face area (especially the nose area and/or under the eyes) area) can be irradiated with a magnetic field.

PEMF, which is a magnetic field generated from the magnetic field generator 130, regenerates and recovers skin by synthesizing Ca2+CaM (ie, by combining Ca2+ with CaM) for the nose and/or under the eyes of the user 1 . , immune-mediated effects, and the like. In addition, PEMF can improve blood viscosity and increase oxygen capacity. In addition, PEMF may cause remodeling, vasoconstriction, vasodilation, and the like, of blood vessels.

The device 100 irradiates PEMF generated from the magnetic field generator 130 to the nose and/or under the eyes of the user 1, thereby regenerating collagen and increasing skin elasticity in the nose and/or under the eyes. , skin tone improvement and rhinitis treatment through excessive vascular changes and blood flow improvement (improving blood flow) can be achieved.

That is, the device 100 can promote blood circulation in the microvessels corresponding to the user's 1 eye area by irradiating the magnetic field to the user 1 under the eye area through the magnetic field generator 130 . In addition, it is possible to supplement (improve) the vitality of the area under the eyes by improving the dark circles under the eyes through the promotion of blood circulation.

In addition, the device 100 improves (improves) the symptoms of darkened skin (for example, dark circles) or areas with many wrinkles or dead skin cells through magnetic field irradiation on the nose and/or under the eyes. can do it

The device 100 may irradiate a magnetic field with respect to the under-eye region of the user 1 through the magnetic field generator 130 , and improvement of blood flow corresponding to the lower-eye region of the user 1 by the irradiated magnetic field It can improve (improvement) dark circles under the eyes. In addition, the apparatus 100 may improve the skin tone of the nose area and/or the area under the eyes through magnetic field irradiation.

The reflection intensity measuring units 150, 151 and 152 are provided to correspond to the front surface of the cushion unit 120, and can measure the reflection intensity of the user 1's nose and/or under the eyes by laser scanning. have. Here, the reflection intensity may mean a degree to which a laser beam irradiated toward the nose and/or under the eyes of the user 1 is reflected (degree of reflection, amount of reflection).

5 and 6 , the reflection intensity measurement unit 150 may include a first reflection intensity measurement unit 151 and a second reflection strength measurement unit 152 . The first reflection intensity measuring unit 151 may be provided to be adjacent to the first magnetic field generating unit 131 , and may be provided to correspond to the first front surface s1 that is the front surface of the first side unit 121 . The second reflection intensity measuring unit 152 may be provided to be adjacent to the second magnetic field generating unit 132 and may be provided to correspond to the second front surface s2 that is the front surface of the second side unit 122 .

Hereinafter, in the description of the apparatus 100, the first reflection intensity measurement unit 151 and the second reflection strength measurement unit 152 even if the description of the reflection intensity measurement unit 150 is omitted below. The same can be applied to the description of each.

The controller 140 may differently control the type of magnetic field generated from the magnetic field generator 130 according to the level of the reflection intensity measured by the reflection intensity measurement unit 150 .

When the level of the reflection intensity measured by the reflection intensity measurement unit 150 is equal to or greater than the preset reference reflection intensity, the control unit 140 sets the type of the magnetic field generated from the magnetic field generator 130 as a first type at a frequency of less than 15 Hz. Any one of the frequencies can be controlled. On the other hand, when the level of the reflection intensity measured by the reflection intensity measurement unit 150 is less than the preset reference reflection intensity, the control unit 140 sets the type of the magnetic field generated from the magnetic field generator 130 as the second type of 15 Hz or more. Any one of the frequencies below 30Hz can be controlled. Here, the preset reference reflection intensity may be expressed differently as the first reflection intensity value.

That is, when the level of the measured reflection intensity is less than the preset reference reflection intensity, the control unit 140 determines that the color of the user 1's nose and/or under the eyes is dark and dark circles are severely present, and the measurement is performed. When the reflected intensity level is greater than or equal to the preset reference reflection intensity, the magnetic field generator (ie, the magnetic field of the second type) is irradiated with a relatively strong magnetic field (ie, the second type of magnetic field) in contrast to the irradiated magnetic field (ie, the first type of magnetic field) 130) can be controlled.

On the other hand, when the measured reflection intensity level is equal to or greater than the preset reference reflection intensity, the color of the user 1's nose and/or under the eyes is bright and dark circles do not exist or dark circles are weakly present. Determining that, the operation of the magnetic field generator 130 may be controlled so that a magnetic field having a relatively weaker strength than that of the second type of magnetic field (ie, the first type of magnetic field) is irradiated.

Here, the relatively strong magnetic field (the second type of magnetic field) refers to the intensity value of the magnetic field compared to the irradiated magnetic field (the first type of magnetic field) when the measured reflection intensity level is greater than or equal to the preset reference reflection intensity. , may mean a magnetic field when at least one of a frequency value and a time value has a large value.

Illustratively, the first type of magnetic field may have a frequency value of any one of frequencies less than 15 Hz as described above as a frequency value. On the other hand, the second type of magnetic field may have a frequency value of any one of 15 Hz or more and 30 Hz or less as described above as a frequency value.

In other words, when controlling the type of the magnetic field as the first type, the controller 140 may control the frequency value of the magnetic field to any one of frequencies less than 15 Hz. On the other hand, when the control unit 140 controls the type of the magnetic field as the second type, the frequency value of the magnetic field relatively larger than the frequency value of the first type (frequency value less than 15 Hz) is a frequency value of 15 Hz or more and 30 Hz or less. It can be controlled by any one frequency value.

At this time, in an example of the present application, the first type of magnetic field has a frequency value of any one of frequencies less than 15 Hz, and the second type of magnetic field has been exemplified as having any one of frequencies of 15 Hz or more and 30 Hz or less. This is only an example for helping understanding of the present application, and is not limited thereto, and the setting ranges of the magnetic field frequency values in the first type and the second type may be variously set.

As another example, the first type of magnetic field may have a value of any one of 1 minute or more and less than 3 minutes as a time value. On the other hand, the second type of magnetic field may have any one of 3 minutes or more and less than 5 minutes as a time value. At this time, in an example of the present application, the time setting of the magnetic field is illustrated as being made in minutes, but it is not limited thereto, and the time unit of the magnetic field in the present application may be variously set to seconds, minutes, hours, etc.

As another example, the first type of magnetic field may have any one of 1 Gauss or more and less than 150 Gauss as the strength value of the magnetic field. On the other hand, the second type of magnetic field may have any one of 150 gauss or more and less than 300 gauss, which is a value greater than the first type magnetic field strength value as the magnetic field strength value.

As such, the control unit 140 controls the type of the magnetic field generated from the magnetic field generator 130 differently based on a preset reference reflection intensity according to the level of the reflection intensity measured by the reflection intensity measurement unit 150 (that is, , If it is higher than the preset standard reflex intensity, it is determined that the color of the nose and/or under the eyes is bright and the type of magnetic field is controlled as the first type, while if it is less than the preset standard reflex intensity, the nose and/or under the eyes The type of magnetic field may be controlled as a second type having a stronger intensity than the first type) by determining that the color of the .

This device 100 is configured according to whether the color of the user 1's nose and/or under the eyes is dark (the brightness of the nose and/or under the eyes divided based on a preset reference reflection intensity). By irradiating different types of magnetic fields to the nose area and/or under-eye area, depending on the condition of each user's nose area and/or under-eye area (i.e., depending on the severity of dark circles according to the level of reflection intensity, According to the darkness of skin tone), the color and vitality of the nose area and/or the area under the eyes may be customized and improved for each user.

The control unit 140 determines the first magnetic field according to the level of the first reflection intensity measured by the first reflection intensity measurement unit 151 and the level of the second reflection intensity measured by the second reflection strength measurement unit 152 . The type of magnetic field generated from each of the generator 131 and the second magnetic field generator 132 may be individually and differently controlled.

In other words, the controller 140 controls each of the left and right nose parts of the user 1 measured by the first reflection intensity measurement unit 151 and the second reflection intensity measurement unit 152 (or under both eyes). The type of magnetic field generated from each of the first magnetic field generating unit 131 and the second magnetic field generating unit 132 may be individually and differently controlled in consideration of the level of reflection intensity for each region).

Hereinafter, for convenience of explanation, a case in which the type of magnetic field generated from each of the two magnetic field generators 131 and 132 is differently controlled in consideration of the level of reflection intensity for each of the parts under the eyes is exemplified, but the present invention is not limited thereto , descriptions of each of the lower eye regions may be equally applied to the descriptions of the left and right nose regions, even if omitted below.

The control unit 140 controls the type of the magnetic field generated from the first magnetic field generator 131 according to the level of the first reflection intensity measured by the first reflection intensity measurement unit 151, while measuring the second reflection intensity. The type of the magnetic field generated from the second magnetic field generator 132 may be controlled according to the level of the second reflection intensity measured through the unit 152 .

Illustratively, when the level of the first reflection intensity measured by the first reflection intensity measurement unit 151 is equal to or greater than a preset reference reflection intensity, the controller 140 controls the magnetic field generated from the first magnetic field generator 131 . The type may be controlled to any one of frequencies less than 15 Hz as the first type. On the other hand, when the level of the second reflection intensity measured by the second reflection intensity measurement unit 152 is less than a preset reference reflection intensity, the control unit 140 determines the type of the magnetic field generated from the second magnetic field generator 132 . As the second type, any one of frequencies between 15 Hz and 30 Hz can be controlled.

In this way, the device 100 is the first reflection intensity measurement unit 151 and the second reflection intensity measurement unit 152 disposed on each of both side portions 124 of the cushion unit 120 of the reflection intensity measured from each of the According to the level (degree), for example, if the color of the right under eye area is darker than the left under eye area among the user's both eyes (that is, the level of the dark circle under the right eye area is the dark circle level under the left eye area) greater than the circle level), the magnetic field (second type of magnetic field) generated from the second magnetic field generator 132 is relatively strong compared to the magnetic field (first type of magnetic field) generated from the first magnetic field generator 131 . The operation of the first magnetic field generator 131 and the operation of the second magnetic field generator 132 may be individually and differently controlled so that the magnetic field of the strength is irradiated.

As another example, the controller 140 determines that the level of the reflection intensity (ie, the second reflection intensity) for the part under the right eye of the user 1 is the level of the reflection intensity for the part under the left eye (ie, the first reflection intensity). When it is determined to be relatively lower than the level, the magnetic field (second magnetic field) irradiated from the second magnetic field generator 132 is relatively strong compared to the magnetic field (first magnetic field) irradiated from the first magnetic field generator 131 . of the magnetic field can be controlled to be irradiated.

Here, the relatively strong magnetic field (second magnetic field) may mean a magnetic field when at least one of the strength value, the frequency value, and the time value of the magnetic field has a larger value compared to the first magnetic field. .

According to this, the apparatus 100 receives the left eye from the first magnetic field generator 131 according to the level of the reflection intensity for each of the left and right under eyes of the user 1 among the under eyes of both sides of the user 1 . The type of magnetic field (first magnetic field) irradiated toward the lower part and the type of magnetic field (second magnetic field) irradiated toward the lower part of the right eye from the second magnetic field generator 132 can be controlled differently by making them different types. have.

In the description of the present application, the left under eye area among the user's lower eye areas (under both eyes) may be referred to as one under eye area, and the right under eye area may be referred to differently as the other under eye area. In this case, as described above, the description of the lower part of the eye on one side is equally applicable to the description of the left nose, and the description of the part under the other eye is equally applicable to the description of the part of the right nose. .

In addition, when controlling the first magnetic field generator 131 to generate the N-pulse magnetic field stimulation, for example, the control unit 140 may control the second magnetic field generation unit 132 to generate the S-pulse magnetic field stimulation. have.

In addition, the control unit 140 is configured such that the first magnetic field generator 131 and the second magnetic field generator 132 alternately generate N pulse magnetic field stimulation and S pulse magnetic field stimulation according to a preset period (that is, N/ The operation of the first magnetic field generator 131 and the second magnetic field generator 132 may be controlled to generate S alternating magnetic field stimulation. Here, the preset period may be set to, for example, 3 seconds, but is not limited thereto.

Referring to FIG. 4 , the upper surface s3 of the cushion unit 120 is formed to prevent at least a portion of the magnetic field irradiated from the magnetic field generator 130 toward the nose portion from reaching the eye portion of the user 1 . It may be made of a magnetic field shielding material capable of shielding the magnetic field (to reduce).

Here, the magnetic field shielding material may be, for example, Permalloy, lead, etc., but is not limited thereto, and various materials and materials capable of shielding the magnetic field may be applied.

As the upper surface s3 of the cushion unit 120 is made of a magnetic field shielding material, the device 100 has a magnetic field irradiated from the magnetic field generator 130, 131, 132 to the user's eye (especially, the eyeball). reach can be minimized. That is, the device 100 may minimize the magnetic field emitted from the magnetic field generator 130 and reaching the eyeball by the upper surface s3 of the cushion unit 120 made of the magnetic field shielding material.

The position adjusting unit 160 may adjust the position of the magnetic field generating unit 130 . Specifically, the position adjusting unit 160 may adjust the position of the first magnetic field generating unit 131 , and for example, the first magnetic field generating unit 131 may be moved in an omnidirectional (overall direction) corresponding to the first front surface s1. ) to move it and adjust its position. Likewise, the position adjusting unit 160 may adjust the position of the second magnetic field generating unit 132 , and for example, the second magnetic field generating unit 132 may be moved in an omnidirectional direction (total direction) in response to the second front surface s2. You can move it and adjust its position.

That is, by adjusting the position by the position adjusting unit 160 , the first magnetic field generating unit 131 can be moved in all directions in the region corresponding to the first front surface s1 , and the second magnetic field is generated. The position of the part 132 may be moved in all directions within the area corresponding to the second front surface s2 . The position adjusting unit 160 may move the magnetic field generating unit 130 in adjusting the positions of the magnetic field generating units 130 , 131 , 132 , and may also control the angle of the magnetic field generating unit 130 . have.

In order to improve the dark circles under the user's eyes, the position adjusting unit 160 may include, for example, the magnetic field generating unit such that each of the two magnetic field generating units 131 and 132 is positioned at a position corresponding to each of the user's both under the eyes. The position of 130 can be adjusted. In addition, in order to improve the user's rhinitis, for example, the position adjusting unit 160 may include a magnetic field generating unit ( ) such that each of the two magnetic field generating units 131 and 132 is positioned at a position corresponding to each of the left and right nose regions. 130) can be adjusted.

The control unit 140 compares the reference intensity with the reference intensity for the skin where dark circles do not occur among the regions under the eyes (or the nose region) of the user 1 where the laser scanning is performed by the reflection intensity measuring unit 150 . Identifies an area out of the dark circle as a dark area in which dark circles exist, and the magnetic field generator ( 160 ) controls the operation so that the center position of the magnetic field generator 130 is positioned at the center position of the identified dark area. 130) can be adjusted.

That is, the control unit 140 controls the position control unit 160 so that the central position of the magnetic field generator 130 is located at the center position of the dark region identified as having dark circles among the regions under the eyes where the laser scanning is performed. You can control the action. According to this, through the operation control of the position adjusting unit 160 by the controller 140, the position adjusting unit 160 so that the central position of the magnetic field generator 130 is on a straight line with the central position of the dark region ( position), the position or angle of the magnetic field generator 130 may be adjusted.

Here, the straight line is an imaginary line connecting the central position of the magnetic field generator 130 and the central position of the dark region, and may be a line perpendicular to the tangent line of the front surface ts of the cushion unit 120 .

In addition, the identification of the region (ie, the dark region) in which the dark circle exists among the regions under the eyes may be identified based on the above-described level of reflection intensity. In addition, the identification of the central position of the dark region may be accomplished through various known or developed central position calculation techniques for calculating the central position within a given specific region.

In this device 100, when irradiating a magnetic field from the magnetic field generator 130, 131, 132, the position adjustment is performed so that the center position of the magnetic field generator 130 is located at the center position of the dark region. By irradiating the magnetic field, the irradiance of the magnetic field to the identified dark region can be made more intensively, thereby effectively improving the dark circles.

That is, in the device 100, the first magnetic field generator 131 is positioned so that the central position of the first magnetic field generator 131 is located at the central position of the identified dark region (first dark region) among the regions under the left eye. ) to adjust the position (or angle) and/or to position the central position of the second magnetic field generator 132 at the central position of the identified dark region (second dark region) among the regions under the right eye. By adjusting the position (or angle) of the magnetic field generator 132 , the magnetic field irradiation to the identified dark region may be more intensively performed, thereby effectively improving dark circles.

In other words, the apparatus 100 sets the position of the magnetic field generator 130 (131, 132) by the position adjusting unit 160 to a position corresponding to the user's nose or to a position corresponding to the user's eye area. It can be controlled to be selectively changed.

For example, the position adjusting unit 160 of the device 100 controls the magnetic field generating unit 130 to move to a position corresponding to the user's nose, for example, in order to maximize the effect of rhinitis treatment (position adjustment) can do.

At this time, for the treatment of rhinitis, the position adjusting unit 160 adjusts the position to be located at a position corresponding to one side of the central front surface cs in the case of the first magnetic field generating unit 131, and the second magnetic field generating unit ( 132), the position may be adjusted to be located at a position corresponding to the other side of the central front surface cs. Here, based on the drawing of FIG. 6, one side of the central front surface cs means the left side with respect to the center point of the central front surface cs, and the other side of the central front surface cs means, It may mean the right side with respect to the center point of the central front surface (cs).

As another example, in order to maximize the effect of improving dark circles, the apparatus 100 may control (position adjustment) to move the magnetic field generator 130 to a position corresponding to the user's under-eye area, for example.

At this time, for the treatment of improving dark circles, the position adjusting unit 160 is positioned to be located at a position corresponding to the first front surface s1, which is the front surface of the first side portion 121 in the case of the first magnetic field generator 131 . , and the position of the second magnetic field generator 132 may be adjusted to be positioned at a position corresponding to the second front surface s2 that is the front surface of the second side portion 122 .

10 is a view for explaining the extension 111 of the rhinitis treatment apparatus 100 according to an embodiment of the present application. In particular, (a) of FIG. 10 shows a front view of the apparatus 100 in a basic state before the expansion operation by the expansion unit 111 is performed, and FIG. 10(b) is a view of the device 100 in a basic state before the expansion operation by the expansion unit 111 is performed. It shows a front view of the present device 100 in an expanded state after the expansion operation is performed.

Referring to FIG. 10 , the body part 110 in the device 100 may include an extension part 111 .

The extension part 111 is provided in the central part 112 of the body part 110, and in response to an external force, compared to before the external force is applied, the extension operation of extending the length of the body part 110 in the left and right direction can be performed. .

Here, the external force is an external force corresponding to a pressing input of a button (referred to as a first button for convenience of explanation) interlocked with the extension 111 provided in one region of the body 110 or both sides of the body 110 . It may be an external force corresponding to a pulling input pulling the parts 113a and 113b in a direction away from the central part 112 .

According to this, the body part 110 is located on the central part 112 , the first side part 113a positioned on one side (eg the left side) of the central part 112 , and the other side (eg the right side) of the central part 112 . and a second side part 113b. That is, the central part 112 , the first side part 113a , and the second side part 113b may be the central part, the first side part, and the second side part of the body part 110 , respectively.

For example, it is assumed that a press input for the first button is generated by the user pressing the first button provided in one region of the body portion 110 . As another example, the user pulls each of the side parts 113a and 113b of the body part 110 in a direction away from the central part 112 of the body part 110, so that a pulling input has occurred with respect to the body part 110. lets do it.

In this case, the extended portion 111 is such that the horizontal length of the body portion 110 is elongated (increased) from the state as in (a) of FIG. 13 to the state as in (b), the length of the body portion 110 . can be extended in the left-right direction. That is, the horizontal length (length in the left and right direction) of the body part 110 may be changed to be longer than before the external force is applied to the body part 110 .

At this time, the extension part 111 has a preset length in comparison with the one end (left end) of the central part 112 before the expansion operation is made with respect to the body part 110 (that is, before the length of the body part is extended). The body portion 110 may be expanded to move by (r). Similarly, the extension 111 has a preset length compared to before the other end (right end) of the central portion 112 is extended with respect to the body 110 (that is, before the length of the body is extended). The body portion 110 may be expanded to move by (r). According to this, according to the expansion operation by the expansion part 111, the horizontal length of the body part 110 may be expanded (increased) by 2r.

In this case, the expansion operation may include a plurality of expansion division operations according to the degree (level) of expansion in the left and right directions.

For example, the length that the body part 110 can extend from the center of the central part 112 toward each of the side parts 113a and 113b by the extension part 111 is a preset length r, and let r be 1 cm. . In this case, r may mean, for example, the maximum length that the body part 110 can extend toward each of both side parts.

The extension unit 111 may perform a plurality of extension division operations. Here, it is assumed that four extended division operations are included as a plurality of extended division operations as an example.

In this case, the first expansion division operation may refer to an operation in which the body part 110 is extended by a length corresponding to 2.5 mm as a preset first length toward each of the side parts 113a and 113b. The second expansion division operation may refer to an operation in which the body part 110 is extended by a length corresponding to 5 mm as a preset second length toward each of the side parts 113a and 113b. The third expansion division operation may refer to an operation in which the body part 110 is extended by a length corresponding to 7.5 mm as a preset third length toward each of the side parts 113a and 113b. The fourth expansion division operation may refer to an operation in which the body portion 110 is extended by a length corresponding to 10 mm (1 cm) as a preset fourth length toward each of the side portions 113a and 113b.

According to this, the expansion unit 111 performs any one of the first expansion division operation to the fourth expansion division operation with respect to the body unit 110 according to the type of pressing input or the type of pulling input through the first button. can make it happen.

Since the expansion operation includes a plurality of expansion division operations (for example, a first expansion division operation to a fourth division division operation), the expansion unit 111 is, for example, a first expansion division operation. The length may be extended (increased) by 2.5 mm to each of the side portions 113a and 113b. As another example, the extension part 111 may extend (increase) by 5 mm to each of the side parts 113a and 113b in the horizontal length of the body part 110 in the case of the second expansion division operation, for example.

In this way, the extension part 111 divides the horizontal length of the body part 110 into a plurality of steps according to the degree of expansion (level) and expands it (ie, as an example of four steps, the first expansion division operation to the fourth step) It can be expanded according to the expansion classification operation). As the length (horizontal length) of the body part 110 is extended by the expansion operation by the expansion part 111 , the first included in both side parts 124 , 121 , 122 of the cushion unit 120 , respectively. A distance between the magnetic field generator 131 and the second magnetic field generator 132 may be adjusted.

According to this, the distance between the parts under the eyes may be different for each user or the size or width of the nose may be different for each user. The device 100 allows the extension part 111 to adjust the horizontal length of the body part 110 . Alternatively, as the distance between the first magnetic field generator 131 and the second magnetic field generator 132 can be adjusted, each user can feel comfortable wearing the device 100 .

In addition, in this device 100, the position of each of the two magnetic field generators 131 and 132 is tailored to the user's appearance (that is, the distance between the user's both eyes and the size and width of the nose are taken into consideration. Therefore, it can be adjusted to fit (position) exactly to the user's under-eye area and nose area, so that magnetic field irradiation can be made for each user's under-eye area and/or nose area, more effectively Magnetic field stimulation can be achieved.

The sleep state determination unit 170 may determine whether the user 1 is in a sleep state. The sleep state determination unit 170 may determine whether the user 1 is in the sleep state by using, for example, at least one of a three-axis acceleration sensor, a pulse measuring sensor, and a respiration measuring sensor. Here, the at least one sensor described above may be disposed in one area of the body part 110 or the cushion unit 120 as an example, but is not limited thereto.

When it is determined by the sleep state determination unit 170 that the user 1 is in the sleep state, the control unit 140 changes the type of the magnetic field generated from the magnetic field generator 130 from the first type to the second type. can Here, the first type means a type of magnetic field generated by the magnetic field generator 130 when the user 1 is not in a sleeping state (ie, in a non-sleep state), and the second type is the user 1 ) may mean a type of magnetic field generated from the magnetic field generator 130 in the sleep state.

In this case, for example, the first type of magnetic field generated in the non-sleep state may mean a magnetic field of relatively strong strength compared to the second type of magnetic field generated in the sleeping state. Since the magnetic field of relatively strong strength has been described in detail above, it will be omitted below.

As such, the control unit 140 may vary the type of magnetic field generated from the magnetic field generator 130 according to the determination result (ie, the determination result of whether the user is in a sleep state) by the sleep state determination unit 170 . There is (can be changed). This device 100 can provide a more comfortable sleep by controlling the strength of the magnetic field irradiated from the magnetic field generator 130 weakly when it is determined that the user 1 is in the sleeping state.

In addition, the device 100 may include a battery unit 180 , a PCB 181 , and fixing supports 190 and 190 ′.

The battery unit 180 may be provided in one region of the body unit 110 and/or the cushion unit 120 . The battery unit 180 may be, for example, a rechargeable battery that can be charged by wire or wirelessly. For example, the battery unit 180 may be, for example, a lithium polymer battery, but is not limited thereto.

The battery unit 180 may be charged by wired communication (ie, an external power source, etc.) and/or wireless communication. Also, although not shown in the drawings, the device 100 may include a charging terminal. The charging terminal may transfer power supplied from the outside to the battery unit 180 for charging the battery unit 180 . That is, the battery unit 180 may be charged by receiving power from the outside by a charging terminal disposed on the body unit 110 . The device 100 may operate using energy stored in the battery unit 180 .

In an example of the present application with reference to FIG. 7 , one battery unit 180 is exemplified as being provided in one region on the left side of the cushion unit 120 , but as another example, the device 100 includes two battery units 180 . can be However, the present invention is not limited thereto, and the location and number of the battery units 180 provided in the device 100 may be variously applied.

Also, the apparatus 100 may include a plurality of printed circuit boards (PCBs) 181 . Communication may be performed between the plurality of PCBs 181 using cables, wires, or the like.

Each component in the device 100 controllable by the controller 140 may be connected (interlocked) to the plurality of PCBs 181 . For example, the magnetic field generators 130 , 131 , 132 , the battery unit 180 , etc. may be connected (interlocked) to the plurality of PCBs 181 .

For example, when the device 100 is in contact with the user's skin (that is, when the rhinitis treatment device is worn on the user's face), the magnetic body (electromagnet) in the first magnetic field generator 131 is the user (1) is disposed at a position corresponding to the left eye area (or left nose area) of the second magnetic field generator 132, and the magnetic material (electromagnet) corresponds to the user 1's right eye area (or right nose area) It can be placed in a position where

The fixed support portions 190 and 190 ′ may be provided on both sides of the body portion 110 , respectively. The fixed support portions 190 and 190 ′ are the first fixed support portion 190 provided on one side (eg, the left side) of the body 110 and the other side (eg, the right side) of the body 110 . It may include a second fixed support 190' provided.

The fixing supports 190 and 190' may include first members 191 and 191', second members 193 and 193', and connecting members 192 and 192'. That is, the first fixing support 190 may include a first member 191 , a second member 193 , and a connecting member 192 . The second fixing support 190 ′ may include a first member 191 ′, a second member 193 ′, and a connecting member 192 ′.

One end of the first members 191 and 191 ′ may be connected to both sides of the body 110 and extend from both sides of the body 110 . The second members 193 and 193' may be connected to the other ends of the first members 191 and 191', and may be disposed in a direction perpendicular to the extending direction of the first members 191 and 191'. The connecting members 192 and 192' may connect the first members 191 and 191' and the second members 193 and 193'. The connecting members 192 and 192' are provided to be movable along the extension direction of the first members 191 and 191' in order to adjust the distance between the body part 110 and the second members 193 and 193'. can

Hereinafter, in describing the fixed supports 190 and 190 ′, for convenience of description, the first fixed support 190 will be described as a reference. Accordingly, the description of the first fixed support 190 may be equally applied to the description of the second fixed support 190 ′ and the fixed support 190 , 190 ′ even if omitted below.

The first fixing support 190 may be provided so that the device 100 can be fixed to a user's face (especially, a nose) and seated (wearing). That is, the first fixing support 190 may be provided to be connected to the side of the body 110 to fix the device 100 to the user's nose or under the eyes.

Specifically, the first fixing support 190 may include a first member 191 , a second member 193 , and a connecting member 192 .

The first member 191 is a member connected to both sides (particularly, the left side) of the body part 110 , and may be formed to extend from the body part 110 . The second member 193 may be a member disposed to be perpendicular to the extending direction of the first member 191 . That is, it may be vertically disposed between the first member 191 and the second member 193 . The connecting member 192 may be a member connecting the first member 191 and the second member 193 to each other.

The second member 193 may be provided to be fixed to the connecting member 192 . The connecting member 192 may be provided in a movable form with respect to the extending direction of the first member 191 (or the longitudinal direction of the first member).

The second member 193 may be provided to be caught on the user's 1 ear when the device 100 is worn on the user's 1's face (nose or under eyes). The distance between the body part 110 and the second member 193 may be adjusted through the movement of the connection member 192 . In other words, the size of the first fixed support 190 may be adjusted through the movement of the connecting member 192 .

An inner surface of the connecting member 192 connected to the first member 191 may have a locking structure. At this time, the locking structure may be formed of a locking structure that allows the connecting member 192 to move along the extending direction of the first member 191 when an external force corresponding to more than a preset force is applied to the connecting member 192. .

According to this, when an external force corresponding to less than a preset force is applied to the connecting member 192 , the connecting member 192 cannot move in the extending direction of the first member 191 and the first member 191 . It can be fixed and caught in a specific position on the top. On the other hand, when an external force corresponding to more than a preset force is applied to the connecting member 192 , the size adjustment may be made as the connecting member 192 is moved in the extending direction of the first member 191 .

Here, in the external force corresponding to less than the preset force, when the device 100 is worn on the user's face, the connecting member 192 cannot move with respect to the extension direction of the first member 191 (movement). An external force corresponding to a force that prevents it from happening) may be included.

Through the size adjustment through the connection member 192, the device 100 is customized to each user so that the device 100 can be comfortably worn by the user using the device 100. can provide

The first fixing support 190 may be made of, for example, silicon, a silicon band, rubber, plastic, or the like, but is not limited thereto.

As an example, the fixed support in the present application may have a shape as shown in FIG. 3 , but is not limited thereto, and as another example, the fixed support may have the following shape.

According to another example of the present application, the first fixing support 190 is a first fixing part connected to one side (eg, the left side) of the body part 110 and the other side (eg, the right side) of the body part 110 . It may include a second fixing part to be connected.

Here, one end of the first fixing part is connected to one side (left side) of the body part 110 , and a weight having a predetermined weight may be provided at the other end of the first fixing part. The first fixing part may be worn (mounted) to be caught on one ear (eg, the left ear) of the user 1 .

Similarly, one end of the second fixing part is connected to the other end (right side) of the body part 110, and a weight having a predetermined weight may be provided at the other end of the second fixing part. The second fixing part may be worn (mounted) to be caught on the other ear (eg, the right ear) of the user 1 .

Accordingly, the front surface (ts) of the device 100 is a weight connected to the other end of the first fixing unit arranged to be caught behind the ear of one side and the weight connected to the other end of the second fixing unit arranged to be caught behind the other ear. By the weight, it may be fixed at a position corresponding to the part under the user's 1 eye.

According to an embodiment of the present application, the first fixing part and the second fixing part may be formed in the form of, for example, a string, a string, etc., but is not limited thereto.

Also, although not shown in the drawings, the apparatus 100 may include a status display unit (not shown).

A status display unit (not shown) may display the operating status of the device 100 .

The status display unit may include, for example, two light sources (not shown) arranged to be spaced apart from each other at a preset interval on the rear surface of the body unit 110 . Here, the light source may be expressed differently as an LED light emitting unit, a light emitting device, a low-output LED unit, and the like. In the present application, the number of light sources included in the status display unit, the shape of the light source (arrangement position), etc. are not limited thereto, and may be provided in various ways. A status display unit (not shown) may control on/off of two light sources.

The status display unit is a light emission type of light emitted from two light sources according to the operating state of the device 100 under the control of the controller 140 , and includes at least one of emission color (color), emission brightness, emission time, and emission pattern. can be controlled.

For example, when it is determined that the remaining amount of the battery unit 180 described later in relation to the operating state of the device 100 is less than or equal to a preset remaining amount, the controller 140 emits a red light from at least one of the two light sources. An operation of the status display unit may be controlled to emit light.

As another example, when the magnetic field is being irradiated from the magnetic field generator 130 in relation to the operating state of the device 100 , the controller 140 may include a status display unit such that blue light is emitted from at least one of the two light sources. operation can be controlled.

As another example, when thermal stimulation is performed from a thermal stimulation unit (not shown), which will be described later in relation to the operating state of the device 100 , the controller 140 emits a green color from at least one of the two light sources. An operation of the status display unit may be controlled to emit light.

As such, the controller 140 may differently control the type of light emitted from at least one of the two light sources according to the operating state of the apparatus 100 .

As an example, the status display unit may be provided to be exposed on the rear surface of the body unit 110 , but is not limited thereto, and may be provided to be exposed to the side surface of the body unit 110 , the front surface ts of the cushion unit 120 , etc. can

In addition, although not shown in the drawings, the device 100 is located on the front surface ts of the cushion unit 120 unlike the status display unit including a light source emitting light for displaying the operating status of the device 100 . It may include a treatment light irradiator (not shown) including a light source for emitting light for light treatment with respect to the corresponding facial region.

At this time, the facial region to which the light emitted from the treatment light irradiating unit is irradiated is a facial region corresponding to the front surface ts of the cushion unit 120 and may particularly mean a region under the eyes, but is not limited thereto. , may refer to a face region including a region under the eyes and a nose region (nose region).

That is, the state display unit may be provided to be exposed on one region of the rear surface of the body 110 to display the operating state of the device 100 . On the other hand, the treatment light irradiator (not shown) is provided to be exposed to the front surface (ts) of the cushion unit 120, the light for the light treatment for the face area (especially, under the eyes or nose area) of the user 1 can be emitted.

The light irradiation unit for treatment (not shown) may include two light sources (a pair of light sources) spaced apart from each other at a distance based on the position of the magnetic body of the magnetic field generating unit 130 and disposed on the front surface ts.

The treatment light irradiator (not shown, hereinafter referred to as a light irradiator) may emit light for light treatment to the face region from two light sources provided on the front surface ts of the cushion unit 120 .

In this case, the light irradiation unit (not shown) may control at least one of a wavelength of light, an emission time of light, and an emission pattern of light as a type of light emitted for phototherapy. The light irradiator (not shown) may simultaneously and integrally control the two light sources or individually control the two light sources.

The light irradiator (not shown) may change the type of light irradiated to the face area according to the type of light treatment. Here, the treatment types include, for example, a first treatment type (acne treatment), a second treatment type (inflammation treatment), a third treatment type (ultraviolet light treatment), a fourth treatment type (scar treatment), and a fifth treatment type (pigmentation treatment). deposition treatment), and the like, but are not limited thereto. In addition, this type of treatment may be selected (set) based on a user input, for example.

The light irradiation unit (not shown) may emit light having any one of wavelengths of 405 nm or more and less than 630 nm toward the face in the case of the first treatment type, for example. The light irradiation unit (not shown) may emit light having any one wavelength of 630 nm or more and less than 660 nm toward the face in the case of the second treatment type, for example. The light irradiation unit (not shown) may emit light having any one of wavelengths of 660 nm or more and less than 970 nm toward the face in the case of the third treatment type, for example. The light irradiator (not shown) may emit light having any one wavelength of 805 nm or more and less than 970 nm toward the face in the case of the fourth treatment type, for example. The light irradiation unit (not shown) may emit light having any one of wavelengths of 870 nm or more and less than 970 nm toward the face in the case of the fifth treatment type, for example.

As such, the light irradiator (not shown) may differently control the type of light irradiated toward the face portion corresponding to the front surface ts of the cushion unit 120 according to the type of treatment.

Also, although not shown in the drawings, the apparatus 100 may include a thermal stimulation unit (not shown).

A thermal stimulation unit (not shown) may be provided on the inside of the front surface ts of the cushion unit 120 and may provide thermal stimulation to the user 1 under the eyes. In other words, the thermal stimulation unit may radiate heat to the area under the eyes, and thus may be expressed differently as a heat emitting unit or the like.

The thermal stimulation unit may be provided inside the front surface ts in the form of a hot wire that generates heat through electric current, for example. However, the present invention is not limited thereto, and the thermal stimulation unit may mean a heating means made of various shapes or materials.

The thermal stimulation part may be arranged to contact the inside of the front surface ts in a zigzag shape such as 'ㄹ' for example. However, the arrangement or shape of the thermal stimulation unit is not limited thereto, and may be variously implemented in an arrangement form that allows heat to be evenly transmitted to the entire front surface ts of the device 100 .

At least one of a temperature, a time, and a pattern of heat emitted from the thermal stimulation unit as a type of thermal stimulation may be controlled by the control unit 140 under the control of the thermal stimulation unit.

When the level of the reflex intensity measured by the reflex intensity measurement unit 150 is greater than or equal to the pre-set reflex intensity, the controller 140 determines that there is keratin in the area under the eyes and controls the operation of the thermal stimulation unit so that thermal stimulation is performed. have.

Here, the preset reflection intensity, which is a standard for judging that there is keratin, is a preset reference reflection that is a reference for determining the severity level of dark circles (or whether there is a dark area) because the color of the area under the eyes described above is dark. It may be set to a value greater than the intensity.

Since keratin is usually white or translucent, if there is keratin under the eyes, the laser (light) irradiated to the area under the eyes may be reflected more compared to the case where there are no dead skin cells under the eyes. . That is, when there is keratin in the area under the eyes, the level of reflex intensity (ie, degree of reflection, amount of reflection) may appear higher than when there is no keratin. In particular, as the amount of keratin increases, the value of reflection intensity may appear as a larger value. Therefore, in the present apparatus 100, the preset reflection intensity value, which is a reference for determining the presence of dead skin cells, is the reference reflection intensity for which the reference is set to determine the level of the above-mentioned dark circles (or whether to determine the existence of a dark region). (or allowable value) may be set to a value larger than the value.

In addition, the control unit 140 controls the type of thermal stimulation as a first type when the level of the reflection intensity measured by the reflection intensity measurement unit 150 is equal to or greater than a preset reflection intensity, and the level of the measured reflection intensity is a preset reflection. If it is less than the intensity, the type of thermal stimulation may be controlled as the second type.

Here, the first type of thermal stimulation may mean a thermal stimulation having a relatively stronger intensity than that of the second type of thermal stimulation. In this case, the relatively strong thermal stimulation (first type of thermal stimulation) may mean a case in which at least one of a heat release temperature value and a time value has a large value compared to the second type of thermal stimulation. have.

Illustratively, the first type of thermal stimulation may have a temperature value of any one of 1 degree or more and 10 or less as a temperature value of heat emission. On the other hand, the second type of thermal stimulation may have a temperature value of any one of a temperature greater than 10 degrees and less than or equal to 20 degrees as a heat emission temperature value.

In other words, when controlling the type of thermal stimulation as the first type, the controller 140 may control the temperature of heat emitted from the thermal stimulation unit to any one of a temperature of 1 degree or more and 10 degrees or less. On the other hand, when controlling the type of thermal stimulation as the second type, the controller 140 may control the temperature of the heat emitted from the thermal stimulation unit to any one of a temperature greater than 10 degrees and less than or equal to 20 degrees.

Similarly, the first type of thermal stimulation may have a value of any one of 1 minute or more and 3 minutes or less, for example, as a heat release time value. On the other hand, the second type of thermal stimulation may have any one of more than 3 minutes and less than or equal to 5 minutes as the heat release time value. In this case, in an example of the present application, although the setting of the heat release time is exemplified in minutes, it is not limited thereto, and the heat release time unit in the present application may be variously set to seconds, minutes, hours, etc.

In addition, although not shown in the drawings, the device 100 is provided on the front surface ts of the water storage unit (not shown) for storing water supplied from the outside, and the cushion unit 120, and is directed toward the area under the eyes. It may include a water spraying unit (not shown) for spraying water.

The water spraying unit (not shown) may spray a predetermined amount of water (a predetermined amount of water, a preset amount of water) among the water stored in the water storage (not illustrated) to the area under the eyes.

When the level of the reflection intensity measured by the reflection intensity measurement unit 150 is greater than or equal to the predetermined reflection intensity, the control unit 140 determines that there is keratin and sprays water toward the area under the eyes (or the nose area). The operation of the master (not shown) may be controlled, and the operation of the thermal stimulation unit may be controlled so that the thermal stimulation is performed thereafter.

The device 100 promotes blood circulation in microvessels corresponding to the area under the eyes (nose) through thermal stimulation of the area under the eyes (or the nose area) to have a cosmetic effect on the area under the eyes (nose area) ( For example, the color and vitality of the surface of the area under the eyes and/or the nose area, improvement of symptoms such as wrinkles or dead skin cells, etc.) may be improved.

Moreover, the device 100 calls off the dead skin cells in the nose and/or under the eyes through a combination of water spray and thermal stimulation, so that the dead skin cells are easily removed from the user 1's nose and/or under the eyes without injury. can make it

Also, although not shown in the drawings, the device 100 may include a moisture level measuring unit (not shown) disposed on the front surface ts to measure the moisture level of the area under the eyes.

When it is determined that the moisture level measured by the moisture level measurement unit (not shown) is less than the preset moisture level value, the control unit 140 determines that the nose and/or under the eyes are dry, and a water spray unit (not shown) It is possible to control to spray a predetermined amount of water through the

In addition, although not shown in the drawings, the device 100 is the skin corresponding to the nose and/or under the eyes, such as oil, moisture, elasticity (elasticity), pore volume, wrinkles, and pigmentation in the area under the eyes. It may include various sensors capable of measuring the state of

The apparatus 100 may non-invasively irradiate a magnetic field to the user's face (especially, under the eyes or on the bridge of the nose). Through this, the device 100 can improve the dark circles by promoting blood circulation in the microvessels under the eyes, and can treat rhinitis of the nose.

Also, the operation of the apparatus 100 may be controlled based on a control signal obtained from a user terminal (not shown).

For example, the control signal obtained from the user terminal includes a control signal related to the type of magnetic field (including a control signal related to setting a magnetic field stimulation mode), a control signal related to the type of thermal stimulation, and a control signal related to position adjustment by the position adjusting unit 160 . etc. may be included.

The apparatus 100 may obtain such a control signal from the user terminal through network communication. That is, the device 100 may be connected (interlocked) with the user terminal through network communication.

Network communication is, for example, a 3rd Generation Partnership Project (3GPP) network, a Long Term Evolution (LTE) network, a World Interoperability for Microwave Access (WIMAX) network, the Internet, a Local Area Network (LAN), and a Wireless Local Area (LAN) network. Network), WAN (Wide Area Network), PAN (Personal Area Network), Bluetooth (Bluetooth) network, NFC (Near Field Communication) network, satellite broadcasting network, analog broadcasting network, DMB (Digital Multimedia Broadcasting) network, etc. Wireless communication may be included, but is not limited thereto.

In addition, the user terminal is PCS (Personal Communication System), GSM (Global System for Mobile communication), PDC (Personal Digital Cellular), PHS (Personal Handyphone System), PDA (Personal Digital Assistant), IMT (International Mobile Telecommunication)-2000 , CDMA (Code Division Multiple Access)-2000, W-CDMA (WCode Division Multiple Access), Wibro (Wireless Broadband Internet) terminal, Smartphone, SmartPad, Tablet PC, Laptop, Wearable Device, Desktop It may include all types of wired and wireless communication devices, such as a PC.

The operation of the apparatus 100 may be controlled based on a control signal obtained from the user terminal, thereby improving user convenience.

In addition, as the device 100 has a portable size (small size), it can be provided so that the user can perform treatment for rhinitis treatment or dark circle improvement (care) regardless of place, anytime, anywhere. have.

The user terminal may provide a beauty solution app (application) that is interlocked with the device 100 to enable the management of schedules or monitoring effects related to rhinitis treatment or dark circle care through the device 100 . The user terminal may provide guide information related to the device 100 used by the user (ie, information on how to use the device, schedule management, etc.) in real time through the beauty solution app.

The controller 140 of the device 100 may provide usage information (use history, usage record) related to the operation of the device 100 by the user to a user terminal and/or a server (not shown).

Here, the usage information includes the operating time of the device 100, the type of operation (operation), the state of the user's under-eye region (ie, the state related to dark circles), and real-time measurement information regarding the state and effect of the nose region. can At this time, the real-time measurement information refers to the state of the user's eye area analyzed based on measurement information such as the level of reflection intensity by the reflection intensity measurement unit 150 and the moisture level by the moisture measurement unit (not shown). , may mean information related to the state and effect of the nose region.

The user terminal and/or the server (not shown) may store the usage information provided from the device 100 into a database for each user. In other words, in relation to the user using the device 100 , the user terminal and/or the server determines the usage time of the device 100 , the dark circle improvement (skin beauty) effect, the rhinitis improvement effect, and the real-time eye area under the eyes. Usage information including status and the like can be stored (recorded) into a database.

The user terminal and/or server (not shown) can enable the user to monitor their condition by providing a beauty solution app based on databased information, and analysis results based on databased information Based on this, we can provide a treatment solution tailored to each individual.

The user terminal and/or server (not shown) may collect data regarding a change in a user's status (change in treatment effect) according to the use of the apparatus 100, and the collected data (ie, collected data from a plurality of users) Based on big data), we can provide customized beauty solutions that are more optimized for each individual.

Herein, the input related to the setting related information of the magnetic field stimulation mode or the position control related information by the position adjusting unit 160 is, for example, a button provided in the device 100 itself (that is, a physical device provided in one region of the body part). in button). However, the present invention is not limited thereto. As another example, the button (physical button) for this input may be made through a button (physical button) provided on the main body (not shown) connected to the device 100 .

In other words, a button (physical button) that receives a signal related to operation control of the apparatus 100 is provided (ie, a physical button) in the apparatus 100 provided with the magnetic field generator 130 to which a magnetic field is irradiated. may be provided in one piece). As another example, the button (physical button) that receives a signal related to operation control of the device 100 is a main body part (physical button) provided separately from the device 100 provided with the magnetic field generator 130 to which a magnetic field is irradiated. not shown) may be provided.

In this case, a connection may be formed between the device 100 and the main body (not shown) by a line, string, or the like capable of transmitting and receiving a control signal. In addition, a line (string) connected between the device 100 and the main body (not shown) is provided, for example, in the form of being wound around a roller in the main body (not shown), and the device 100 is removed from the main body (not shown). When an external force such as pulling is applied, the wire may be unwound from the roller. That is, the line connected between the apparatus 100 and the main body (not shown) may be wound or unwound on a roller in the main body (not shown).

When the body part (not shown) is provided, the body part (not shown) may be formed to be connected to the body part 110 in the form of a line extending with respect to the apparatus 100 provided with the magnetic field generator 130 . .

In the present application, by applying a pulsed magnetic field to the user's under-eye region through the device 100, blood flow in the under-eye region is increased and cells are stimulated to improve the physiology of the under-eye region and at the same time have a cosmetic effect (that is, improve dark circles) effect) can be obtained. In addition, in the present application, by applying a pulsed magnetic field to the user's nose by adjusting the position of the magnetic field generator 130 through the device 100, rhinitis treatment for the nose can be performed.

The present application can provide effects such as improvement of tone (brightness) or wrinkle improvement of the user's under-eye area and/or nose area through the promotion of blood circulation (improvement of blood flow) by the device 100, and periodic use can provide a permanent cosmetic effect.

The device 100 is effective in improving blood circulation in the user's face area through magnetic field irradiation for the area under the eyes and/or the nose area, thereby promoting blood circulation in microvessels in the face area to improve skin tone can do.

In addition, the device 100 can increase only the blood flow in the area under the eyes without harm to the skin or muscles through the application of a pulsed magnetic field of a very low frequency, so that the skin tone (eg, dark circles) can be naturally improved. can The apparatus 100 may improve the user's physiological problems under the eyes and/or the nose, as well as improve the aesthetics. That is, the present application can improve the tone and health of the lips by improving blood flow in the area under the eyes.

The present device 100 is capable of improving (treatment) of dark circles based on PEMF, and has no side effects and a large improvement effect compared to conventional dark circle treatment techniques. The present application may provide the apparatus 100 as an IOT-based beauty device in consideration of user convenience.

Beauty devices usually need to be used for more than a few minutes, so size, weight, and convenience need to be considered. Accordingly, the present application may provide the device 100 which is formed in a small and light size so that the user can carry and use it with one hand.

In addition, in consideration of the fact that the magnetic field is invisible to the naked eye, the present application displays the operating state of the apparatus 100 through a light source (LED) of a status display unit (not shown), so that the use state of the apparatus 100 is determined by the user. It can be provided so that it can be perceived more intuitively.

The apparatus 100 may be controlled by a user terminal. In addition, the present application may allow the user to check the usage-related information of the device 100 through the beauty solution app provided on the user terminal. For example, a function such as a timer and magnetic field stimulation mode selection may be implemented in the beauty solution app. The operation of the device 100 may be controlled through such a beauty solution app-based control.

The device 100 may transmit the usage record of the device 100 to a user terminal and/or a server (not shown), and the user terminal may remotely (wirelessly) control the operation of the device 100 . Accordingly, user convenience can be further improved.

Dark circles refer to a phenomenon in which the area under the user's eyes appears black due to reasons such as not sleeping late, large emotional fluctuations, asthenia, and aging, which cause inconvenience as not only health problems but also aesthetic problems. In consideration of this, the present application proposes the present device 100 as a device capable of caring for (improving) dark circles, that is, restoring and improving the color (tone) of the skin corresponding to the area under the eyes.

The device 100 has a curved surface according to the shape of the user's eye area or nose area (nose bridge area) and has a size that covers the entire area under the eyes of the user 1 on both sides of the front surface (ts). Accordingly, the entire area under both eyes of the user 1 is covered (covered) and in contact with each other, so that the magnetic field is evenly irradiated to the entire area under both eyes of the user 1 . In addition, the device 100 can be easily carried due to its small size.

In the above description, the present apparatus 100 has been exemplified as including the two magnetic field generators 131 and 132 as the magnetic field generator, but the present invention is not limited thereto, and the number may be variously applied.

14 is a view showing an example of the magnetic field generator 130 in the rhinitis treatment apparatus 100 according to an embodiment of the present application.

Referring to FIG. 14 , the magnetic field generator 130 may be an electromagnet including a core and a coil. The magnetic flux density of the electromagnet that is the magnetic field generator 130 considered in the apparatus 100 may satisfy the condition of the equation shown in FIG. 14 . As performance indicators of the electromagnet, electromagnetic inductance, total impedance, magnetic flux density, and PEMF pulse property may be considered.

15 is a diagram for explaining a design example of a small electronic circuit as hardware included in the rhinitis treatment apparatus 100 according to an embodiment of the present application.

Referring to FIG. 15 , the electronic circuit of the device 100 may include a current driver, an H-bridge, a thermal electric control, a boost-up, and the like. can That is, the device 100 may perform the following functions according to each component included in the electronic circuit.

The current driver functions as a circuit to implement a target current value in relation to the magnetic field generator 130 , and may be related to magnetic flux density. The H-bridge may provide control of the direction of current in relation to the magnetic field generator 130 and realization of the bi-phasic pulse. Thermal electric control may control overheating of the electromagnet in relation to the magnetic field generator 130 , and may adjust a current or a duty ratio. The boost-up may increase the voltage of the low-voltage battery, for example, increase the voltage from 3.3 V to 12 V.

16 is a view for explaining the frequency of the magnetic field generated from the magnetic field generator 130 of the rhinitis treatment apparatus 100 according to an embodiment of the present application.

Referring to FIG. 16 , the controller 140 may control the operation of the magnetic field generator 130 , and in particular may control the type of the magnetic field of the magnetic field generator 130 . Here, the type of the magnetic field may include at least one of strength, frequency, time, and pattern of the magnetic field. Under the control of the controller 140 , the magnetic field generator 130 may generate a magnetic field.

The magnetic field generator 130 may suppress the dilated blood vessels by generating a magnetic field having a frequency of 10 Hz or less, for example.

In addition, the magnetic field generator 130 may generate a magnetic field having a frequency exceeding 10 Hz, for example, thereby increasing blood flow in a local area and providing electroporation.

17 is a view for explaining an example of a small drive hardware included in the rhinitis treatment apparatus 100 according to another embodiment of the present application.

Referring to FIG. 17 , the device 100 includes a lithium polymer battery (Li-po battery) 180 and a first magnetic field generator 131 positioned to correspond to the lower left eye area for the development of small driving hardware. It may include an electromagnet, an electromagnet in the second magnetic field generator 132 positioned to correspond to the part under the right eye, a stacked PCB 181 , a control circuit, and a vibration motor.

The controller 140 may display the operation state through the control of the above-described state display unit (not shown) in notifying the operation state of the device 100 . However, the present invention is not limited thereto, and the controller 140 may notify the operation state of the apparatus 100 through vibration through operation control of the vibration motor included in the apparatus 100 . That is, the device 100 displays (notifies) the operating state of the device 100 through an LED display through a status display unit (not shown) or generates vibration through a vibration motor, and the remaining amount of the battery unit 180 . etc. can be displayed.

According to the small driving hardware included in the device 100 , the device 100 may implement a precision control circuit of an electromagnet, and verify and optimize a test circuit function. In addition, according to the small driving hardware included in the device 100 , the device 100 may determine a BOM and circuit specifications, and may enable PCB ARTWORK and sample inspection.

18 is a view schematically showing the shape of the rhinitis treatment apparatus 100 according to an embodiment of the present application. In other words, FIG. 18 is a diagram schematically illustrating an ergonomic design and a design diagram of a precision instrument in relation to the present device 100 .

Referring to FIG. 18 , the device 100 may be designed (designed, manufactured) in consideration of the user's human body structure. The device 100 may be provided in a size so that it crosses the bridge of the nose among the user's nose parts and covers the parts under both eyes.

The device 100 may further alleviate symptoms of rhinitis, dark circles, or skin blemishes by promoting blood circulation.

Hereinafter, an operation flow of the present application will be briefly reviewed based on the details described above.

11 is an operation flowchart for a method of driving a rhinitis treatment apparatus according to an embodiment of the present application.

The driving method of the rhinitis treatment apparatus shown in FIG. 11 may be performed by the present apparatus 100 described above. Therefore, even if omitted below, the contents described for the apparatus 100 may be equally applied to the description of the driving method of the rhinitis treatment apparatus.

Referring to FIG. 11 , in step S11 , the controller 140 generates a magnetic field provided to correspond to the front surface of the cushion unit provided to be in contact with the front surface of the body portion provided to cover the user's nose and/or under the eyes. You can control the negative behavior.

Here, the cushion unit may provide a cushioning feeling to the user's skin and may have a front surface in contact with the user's skin.

In addition, the central portion of the cushion unit may be recessed in a rearward direction compared to both side portions of the cushion unit. In addition, the central front surface of the central portion may be a surface provided at a position corresponding to the user's nose (particularly, the bridge of the nose) when the rhinitis treatment device is in contact with the user's skin.

In addition, both side portions, the first side portion provided on one side of the central portion; and a second side portion provided on the other side of the central portion. The first front surface, which is the front surface of the first side part, and the second front surface, which is the front surface of the second side part, may refer to a surface provided at a position corresponding to the user's eye area.

Next, in step S12, the magnetic field generator 130 may irradiate the magnetic field toward the user's nose and/or under the eyes under the control in step S11. By the magnetic field irradiated toward the nose in step S12, rhinitis treatment for the user's nose can be performed. In addition, by the magnetic field irradiated toward the under-eye area in step S12, the dark circles under the eye may be improved by improving blood flow corresponding to the under-eye area.

In addition, in step S11, the controller may control at least one of strength, frequency, time, and pattern of the magnetic field as a type of magnetic field generated from the magnetic field generator.

In addition, although not shown in the drawings, the driving method of the rhinitis treatment apparatus according to an embodiment of the present application uses laser scanning through the reflection intensity measurement unit provided to correspond to the front surface of the cushion unit, under the user's nose and/or under the eyes. It may include a step (hereinafter referred to as step S13 for convenience of description) of measuring the reflection intensity for the region.

In step S11, the controller may differently control the type of magnetic field generated from the magnetic field generator according to the level of the reflection intensity measured in step S13.

In addition, in step S11, when the level of the reflection intensity measured in step S13 is equal to or greater than a preset reference reflection intensity, the control unit may control the magnetic field type to be any one of frequencies less than 15 Hz as the first type. In addition, in step S11, when the level of the reflection intensity measured in step S13 is less than the preset reference reflection intensity, the type of the magnetic field can be controlled to any one of frequencies of 15 Hz or more and 30 Hz or less as the second type. have.

In the above description, steps S11 to S13 may be further divided into additional steps or combined into fewer steps, according to an embodiment of the present application. In addition, some steps may be omitted as necessary, and the order between steps may be changed.

In the above description, steps S11 to S15 may be further divided into additional steps or combined into fewer steps, according to an embodiment of the present application. In addition, some steps may be omitted as necessary, and the order between steps may be changed.

The driving method of the rhinitis treatment apparatus according to an embodiment of the present application may be implemented in the form of a program command that can be executed through various computer means and recorded in a computer-readable medium. The computer-readable medium may include program instructions, data files, data structures, etc. alone or in combination. The program instructions recorded on the medium may be specially designed and configured for the present invention, or may be known and available to those skilled in the art of computer software. Examples of the computer-readable recording medium include magnetic media such as hard disks, floppy disks and magnetic tapes, optical media such as CD-ROMs and DVDs, and magnetic such as floppy disks. - includes magneto-optical media, and hardware devices specially configured to store and execute program instructions, such as ROM, RAM, flash memory, and the like. Examples of program instructions include not only machine language codes such as those generated by a compiler, but also high-level language codes that can be executed by a computer using an interpreter or the like. The hardware devices described above may be configured to operate as one or more software modules to perform the operations of the present invention, and vice versa.

In addition, the above-described driving method of the rhinitis treatment apparatus may be implemented in the form of a computer program or application executed by a computer stored in a recording medium.

The above description of the present application is for illustration, and those of ordinary skill in the art to which the present application pertains will understand that it can be easily modified into other specific forms without changing the technical spirit or essential features of the present application. Therefore, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. For example, each component described as a single type may be implemented in a distributed manner, and likewise components described as distributed may be implemented in a combined form.

The scope of the present application is indicated by the following claims rather than the above detailed description, and all changes or modifications derived from the meaning and scope of the claims and their equivalents should be construed as being included in the scope of the present application.

100: rhinitis treatment device
110: body part
120: cushion unit
130: magnetic field generator
140: control unit
150: reflection intensity measurement unit
160: position control unit
170: sleep state determination unit
180: battery unit
190, 190': fixed support

Claims (20)

As a rhinitis treatment device,
a body portion provided to cover the user's nose;
a cushion unit provided to be in contact with the front surface of the body part, having a front surface in contact with the user's skin, and providing a cushioning feeling to the skin;
a magnetic field generator provided to correspond to the front surface of the cushion unit and irradiating a magnetic field toward the nose; and
A control unit for controlling the operation of the magnetic field generator,
The rhinitis treatment device for rhinitis treatment of the nose area by the magnetic field irradiated from the magnetic field generator. According to claim 1,
The central portion of the cushion unit is recessed in the rear direction compared to both side portions of the cushion unit,
The central front surface, which is the front surface of the central part, is a surface provided at a position corresponding to the user's nose bridge when the rhinitis treatment device is in contact with the user's skin, the rhinitis treatment device. 3. The method of claim 2,
The both side parts,
a first side portion provided on one side of the central portion; and
It includes a second side portion provided on the other side of the central portion,
The first front surface, which is the front surface of the first side part, and the second front surface, which is the front surface of the second side part, is a surface provided at a position corresponding to the user's eye area, rhinitis treatment apparatus. 3. The method of claim 2,
The control unit is
As a type of magnetic field generated from the magnetic field generator, the intensity, frequency, time and pattern of the magnetic field will be controlled at least one of the, rhinitis treatment device. 5. The method of claim 4,
It is provided to correspond to the front surface of the cushion unit, and further comprises a reflection intensity measuring unit for measuring the reflection intensity of the user's nose and / or under the eyes by laser scanning,
The control unit, the type of magnetic field generated from the magnetic field generating unit according to the level of the measured reflection intensity will be different, rhinitis treatment device. 6. The method of claim 5,
The control unit is
When the level of the measured reflection intensity is greater than or equal to a preset reference reflection intensity, the type of the magnetic field is controlled to any one of frequencies less than 15 Hz as the first type,
When the level of the measured reflection intensity is less than a preset reference reflection intensity, the type of the magnetic field is controlled to any one of the frequencies of 15 Hz or more and 30 Hz or less as a second type, rhinitis treatment device. 6. The method of claim 5,
The magnetic field generator may include a first magnetic field generator provided to correspond to the first front surface of the first side part among the both side parts and a second magnetic field generator part provided to correspond to the second front surface of the second side part among the both side parts. including,
The reflection intensity measuring unit is provided to be adjacent to the first magnetic field generating unit and provided to be adjacent to the first reflection strength measuring unit and the second magnetic field generating unit which are provided to correspond to the first front surface and correspond to the second front surface. Which will include a second reflection intensity measurement unit provided so as to, rhinitis treatment device. 8. The method of claim 7,
The control unit is
From each of the first magnetic field generator and the second magnetic field generator according to the level of the first reflection intensity measured through the first reflection intensity measurement unit and the level of the second reflection intensity measured through the second reflection strength measurement unit The type of magnetic field that is generated is to control each individually differently, rhinitis treatment device. 9. The method of claim 8,
The control unit is
When the first magnetic field generator controls to generate N-pulse magnetic field stimulation, the second magnetic field generator controls to generate S-pulse magnetic field stimulation,
Controlling the first magnetic field generator and the second magnetic field generator so that the first magnetic field generator and the second magnetic field generator alternately generate N-pulse magnetic field stimulation and S-pulse magnetic field stimulation according to a preset period , rhinitis treatment device. 3. The method of claim 2,
At least in a portion of the front surface of the cushion unit, the rhinitis treatment device will be provided with an anti-slip part having a predetermined fixing force so as not to slip on the skin when the rhinitis treatment device is in contact with the user's skin. According to claim 1,
The upper surface of the cushion unit is made of a magnetic field shielding material capable of shielding the magnetic field in order to prevent at least a portion of the magnetic field irradiated from the magnetic field generator toward the nose portion from reaching the user's eye area. treatment device. 6. The method of claim 5,
Further comprising a position adjusting unit for adjusting the position of the magnetic field generating unit,
The control unit is
Among the areas under the eyes where the laser scanning is performed, an area that is out of the allowable value compared to the reference intensity for skin where dark circles do not occur is identified as a dark area where dark circles exist, and the center position of the identified dark area To adjust the position of the magnetic field generating unit through the operation control of the position adjusting unit so that the central position of the magnetic field generating unit is located in, rhinitis treatment device. According to claim 1,
The body part,
An extension part provided in the central part of the body part and performing an expansion operation of extending the length of the body part in the left and right directions in response to an external force;
A rhinitis treatment device further comprising a. 14. The method of claim 13,
The external force is an external force corresponding to an external force corresponding to a pressing input of a button provided in one region of the body or an external force corresponding to a pulling input of pulling both side parts of the body in a direction away from the central part. 15. The method of claim 14,
The expansion operation is
According to the degree of expansion in the left and right directions, which includes a plurality of expansion division operations, rhinitis treatment device. 5. The method of claim 4,
Further comprising a sleep state determination unit for determining whether the user is in a sleep state,
The control unit is
When it is determined by the sleep state determination unit that the user is in a sleep state, the type of magnetic field generated from the magnetic field generator is changed from the first type to the second type, rhinitis treatment device. According to claim 1,
Further comprising a fixed support provided on each side of the body portion,
The fixed support portion,
a first member having one end connected to both sides of the body and extending from both sides of the body;
a second member connected to the other end of the first member and disposed in a direction perpendicular to an extension direction of the first member; and
a connecting member connecting the first member and the second member;
That comprising a, rhinitis treatment device. 18. The method of claim 17,
The connecting member is
For adjusting the distance between the body portion and the second member, the rhinitis treatment device that is provided to be movable along the extension direction of the first member. As a driving method of the rhinitis treatment device of claim 1,
controlling, by the control unit, the operation of the magnetic field generator provided to correspond to the front surface of the cushion unit provided to be in contact with the front surface of the body portion provided to cover the user's nose;
A magnetic field generating unit comprising the step of irradiating a magnetic field toward the nose area by the control,
Rhinitis treatment for the nose area is made by the magnetic field irradiated from the magnetic field generator,
The cushion unit provides a cushioning feeling for the user's skin and has a front surface in contact with the user's skin, the driving method of the rhinitis treatment device. A computer-readable recording medium recording a program for executing the method of claim 19 on a computer.

Images